FDA Advisory Panel
FDA Panel urges ban on phenylpropanolamine-containing OTC cold
remedies
United States FDA
(Oct) 10:Oct 19th, 2000

Reuters news story can be found at
this
link.
This is only an advisory panel recommendation, based on the finding of a
slightly elevated stroke risk in patients aged 18-49 who took cold remedies
containing phenylpropanolamine.